MDS-520 A Phase I/II Study of Venetoclax in Combination With ASTX727 (Decitabine/Cedazuridine) in Treatment-Naïve High-Risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Sangeetha Venugopal, Hagop Kantarjian, Abhishek Maiti, Nicholas J. Short, Guillermo Montalban-Bravo, Yesid Alvarado, Kelly Chien, Rashma Kanagal-Shamanna, Naveen Pemmaraju, Naval Daver, Tapan Kadia, Gautam Borthakur, Elias Jabbour, Guillermo Garcia-Manero

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'MDS-520 A Phase I/II Study of Venetoclax in Combination With ASTX727 (Decitabine/Cedazuridine) in Treatment-Naïve High-Risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)'. Together they form a unique fingerprint.

Medicine & Life Sciences